IncobotulinumtoxinA (Xeomin)

DRUG3 trials

Sponsors

Merz Pharmaceuticals GmbH

Conditions

BlepharospasmLateral Periorbital WrinklesPost-stroke Upper Limb Spasticity

Phase 3

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Blepharospasm

CompletedNCT00406367

Merz Pharmaceuticals GmbHBlepharospasm

Start: 2006-10-31End: 2009-07-31Updated: 2013-03-15

IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Post-stroke Spasticity of the Upper Limb

CompletedNCT00432666

Merz Pharmaceuticals GmbHPost-stroke Upper Limb Spasticity

Start: 2006-06-30End: 2008-05-31Updated: 2010-12-15

Efficacy and Safety of NT 201 in the Treatment of Lateral Periorbital Wrinkles

CompletedNCT00541723

Merz Pharmaceuticals GmbHLateral Periorbital Wrinkles

Start: 2007-09-30End: 2008-05-31Updated: 2012-03-08

Related Papers

Duration of Treatment Effect Using IncobotulinumtoxinA for Upper-limb Spasticity: A Post-hoc Analysis

Frontiers in Neurology2021-01-222 citations

Sustained efficacy of incobotulinumtoxina repeated injections for upper-limb post-stroke spasticity: A post hoc analysis.

2021-01-052 citations